Awarded contractNeg Wo CallSuppliesGermany
Arzneimittelrahmenrabattvertrag gemäß § 130c Absatz 1 des Fünften Sozialgesetzbuchs - Ocrevus (Wirkstoff: Ocrelizumab), ATC L04AG08
1 supplier awarded•1 lot awarded•€1 awarded
Buyer: DAK-Gesundheit / Hamburg, Germany
Published Jul 17, 2024Awarded Jul 02, 2024
Pharmaceutical products
Awarded value
€1.0
Estimated value
€1.0
Awarded at 100% of estimated value
Award date
Jul 02, 2024
Winners
1
Lots awarded
1